Akeso

Summit
Favicon Fierce Pharma

Summit's global PD-1xVEGF data show new promising OS trend

With a fresh data cut in September, the death risk reduction by the ivonescimab regimen expanded to 22% with an improved nominal p value of 0.0332.
Angus Liu Sep 7, 2025 3:30am
Akeso
Favicon Fierce Pharma

Akeso, Summit's PD-1xVEGF drug meets OS goal for the first time

Aug 26, 2025 11:36am
golf in hole

Akeso scores twice in phase 3, tees up regulatory submission

Aug 25, 2025 1:37pm
Realistic white price tags collection Special offer or shopping discount label

China biotechs ‘reshaping’ US biopharma: Jefferies report

Jul 14, 2025 2:30pm
Question
Favicon Fierce Pharma

Summit in high-stakes deal talks with AstraZeneca: Bloomberg

Jul 7, 2025 10:45am
Photo of a person celebrating at the top of the mountain while the sun setsrises

Akeso's bispecific notches ph. 3 victory against gastric cancer

Nov 7, 2023 10:50am